PTEN and skeletal muscle disorder: PTEN mRNA, a validated miR‐486‐5p target reported in several studies including kidney [15] and cardiac I/R injury [11, 35], skeletal muscle disorders [36] and ischaemic stroke [21], was not identified in our miR‐486‐5p pulldown.